TREA

85441411 - GLYCOSYN

Follow

Information

  • Trademark
  • 85441411
  • Serial Number
    85441411
  • Registration Number
    4315578
  • Filing Date
    October 06, 2011
    13 years ago
  • Registration Date
    April 09, 2013
    12 years ago
  • Transaction Date
    October 24, 2023
    a year ago
  • Status Date
    September 18, 2023
    a year ago
  • Published for Opposition Date
    September 18, 2012
    12 years ago
  • Renewal Date
    April 09, 2023
    2 years ago
  • Location Date
    September 18, 2023
    a year ago
  • Status Code
    800
  • Current Location
    GENERIC WEB UPDATE
    Employee Name
    CLAYTON, CHERYL A
  • Attorney Docket Number
    481263.201
    Attorney Name
    Kevin S. Costanza
    Law Office Assigned Location Code
    L20
  • Owners
Information
Mark Drawing Code
4000
Mark Identification
GLYCOSYN
Case File Statements
  • GS0051: Active pharmaceutical ingredients sold as an integral component of pharmaceutical preparations for the treatment of pain, inflammation, infection, diabetes, cancers and for wound repair; pharmaceutical ingredients used in enzyme replacement therapies, therapeutic vaccines (adjuvants), stem cell therapies, and for enhanced drug delivery; antioxidants; vaccines for the treatment of cancer; adjuvants and antigens for vaccines; active veterinary ingredients sold as an integral component of veterinary preparations for the treatment of bloat and for improving fecundity; herbicides and pesticides for commercial, agricultural or industrial use
  • GS0011: Carbohydrate-derived chemicals and peptides for use in industry; chemical additives for use in the manufacture of pharmaceuticals and cosmetics
  • GS0421: Scientific and technological research services in the fields of biotechnology, carbohydrate chemistry and pharmaceuticals including research services in the field of pharmaceutical and drug manufacture; biological, pharmaceutical and medical research; testing services, namely, testing, inspection or research of pharmaceuticals and drugs; laboratory services, namely, chemical synthesis of active pharmaceutical intermediates (APIs) for use in pre-clinical and human clinical trials; pharmaceutical research and development services, namely, active pharmaceutical intermediates (APIs) research and development to support pre-clinical and early phase human clinical trials; chemical laboratory analytical services, namely, analyzing pharmaceuticals and potential pharmaceutical ingredients
Case File Event Statements
  • 9/18/2023 - a year ago
    33 - NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED Type: NA89
  • 9/18/2023 - a year ago
    32 - REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) Type: RNL1
  • 9/18/2023 - a year ago
    31 - REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED Type: 89AG
  • 9/18/2023 - a year ago
    30 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE
  • 3/10/2023 - 2 years ago
    29 - TEAS SECTION 8 & 9 RECEIVED Type: E89R
  • 4/9/2022 - 3 years ago
    28 - COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED Type: REM2
  • 5/21/2019 - 5 years ago
    27 - NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED Type: NA85
  • 5/21/2019 - 5 years ago
    26 - REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. Type: C15A
  • 5/21/2019 - 5 years ago
    25 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE
  • 4/9/2019 - 6 years ago
    24 - TEAS SECTION 8 & 15 RECEIVED Type: E815
  • 4/9/2018 - 7 years ago
    23 - COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Type: REM1
  • 8/5/2015 - 9 years ago
    22 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Type: ASGN
  • 4/9/2013 - 12 years ago
    21 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 1/14/2013 - 12 years ago
    20 - 1(B) BASIS DELETED; PROCEED TO REGISTRATION Type: DP1B
  • 1/7/2013 - 12 years ago
    19 - NOTICE OF ALLOWANCE CANCELLED Type: IUCN
  • 1/14/2013 - 12 years ago
    18 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU
  • 1/7/2013 - 12 years ago
    17 - TEAS POST PUBLICATION AMENDMENT RECEIVED Type: EPPA
  • 11/13/2012 - 12 years ago
    16 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 9/18/2012 - 12 years ago
    15 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 9/18/2012 - 12 years ago
    14 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 8/29/2012 - 12 years ago
    13 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 8/14/2012 - 12 years ago
    12 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV
  • 8/14/2012 - 12 years ago
    11 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 7/18/2012 - 12 years ago
    10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 7/18/2012 - 12 years ago
    9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 7/13/2012 - 12 years ago
    8 - ASSIGNED TO LIE Type: ALIE
  • 7/3/2012 - 12 years ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 1/31/2012 - 13 years ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 1/31/2012 - 13 years ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 1/31/2012 - 13 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 1/25/2012 - 13 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 10/13/2011 - 13 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 10/10/2011 - 13 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP